• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Beta Bionics, Inc. - Common Stock (NQ:BBNX)

    16.43 +0.76 (+4.85%)
    Streaming Delayed Price Updated: 10:54 AM EDT, Jul 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 121,285
    Open 15.91
    Bid (Size) 16.41 (300)
    Ask (Size) 16.45 (100)
    Prev. Close 15.67
    Today's Range 15.88 - 16.59
    52wk Range 8.800 - 32.71
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
    From Beta Bionics, Inc.
    Via GlobeNewswire
    News headline image
    Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
    From Johnson Fistel, PLLP
    Via Business Wire

    Performance

    YTD
    -43.8%
    -43.8%
    1 Month
    +28.4%
    +28.4%
    3 Month
    +64.0%
    +64.0%
    6 Month
    -48.6%
    -48.6%
    1 Year
    +12.8%
    +12.8%

    More News

    Read More
    News headline image
    Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel
    From Johnson Fistel, PLLP
    Via Business Wire
    News headline image
    Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
    From Beta Bionics, Inc.
    Via GlobeNewswire
    Beta Bionics Inc (NASDAQ:BBNX) Beats Q1 2026 Estimates and Raises Full-Year Guidance ↗
    Via Chartmill
    News headline image
    Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
    From Robbins LLP
    Via Business Wire
    News headline image
    Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
    From Beta Bionics, Inc.
    Via GlobeNewswire
    News headline image
    Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans ↗
    Via MarketBeat
    News headline image
    Beta Bionics to Present at the Bank of America Securities Health Care Conference
    From Beta Bionics, Inc.
    Via GlobeNewswire
    News headline image
    Beta Bionics BBNX Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
    From Beta Bionics, Inc.
    Via GlobeNewswire
    News headline image
    Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care
    From Beta Bionics, Inc.
    Via GlobeNewswire
    News headline image
    Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
    From Beta Bionics, Inc.
    Via GlobeNewswire
    News headline image
    BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Beta Bionics (NASDAQ: BBNX)
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
    From Beta Bionics, Inc.
    Via GlobeNewswire
    News headline image
    BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Beta Bionics (BBNX) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Beta Bionics, Inc. - Common Stock publicly traded?
    Yes, Beta Bionics, Inc. - Common Stock is publicly traded.
    What exchange does Beta Bionics, Inc. - Common Stock trade on?
    Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Beta Bionics, Inc. - Common Stock?
    The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market
    What is the current price of Beta Bionics, Inc. - Common Stock?
    The current price of Beta Bionics, Inc. - Common Stock is 16.43
    When was Beta Bionics, Inc. - Common Stock last traded?
    The last trade of Beta Bionics, Inc. - Common Stock was at 07/01/26 10:54 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.